Sudhir Srivastava
Sudhir Srivastava is chief of the Cancer Biomarkers Research Group of the Division of Cancer Prevention at the United States NCI. Srivastava has held this position since 2000. He is a co-author of the Bethesda Guidelines for the diagnosis of Hereditary non-polyposis colorectal cancer (HNPCC).Srivastava is an elected member of the American Joint Committee on Cancer (AJCC), responsible for developing cancer staging criteria, and serves on the AJCC Executive Committee and the All Ireland-NCI Consortium. Srivastava is a founding member of HUPO, participated in the Plasma Proteome and the Liver Proteome Projects, and supported several HUPO-supported initiatives. Provided by Wikipedia
-
1
-
2
-
3
-
4
-
5by Mitra Somenath, Avedisian C Thomas, Cavicchi Richard E, Holbrook R David, Urbas Aaron, Treado Stephen, Taratula Oleh, Gao Xiugong, Xiao Yan, Savla Ronak, Wagner Paul D, Srivastava Sudhir, He HuixinGet full text
Published 2009-10-01
Article -
6by Wagner Paul D, Barker Peter E, Maitra Anirban, Hoque Mohammad O, Greenberg Alissa K, Markowitz Maura E, Maragh Samantha, Jakupciak John P, Rom William N, Srivastava Sudhir, Sidransky David, O'Connell Catherine DGet full text
Published 2008-10-01
Article -
7by Thayer Robert E, Wagner Paul D, Robinson Kerry, Wittock Roy, Maki Katrina, Reguly Brian, Maki Jennifer, Maragh Samantha, Maggrah Andrea, Jakupciak John P, Gehman Ken, Gehman Teresa, Srivastava Sudhir, Ngom Alioune, Dakubo Gabriel D, Parr Ryan LGet full text
Published 2008-04-01
Article